Dimensional Fund Advisors LP Has $13.64 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO)

Dimensional Fund Advisors LP increased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 10.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,488,667 shares of the medical instruments supplier’s stock after acquiring an additional 135,007 shares during the quarter. Dimensional Fund Advisors LP owned approximately 3.68% of AngioDynamics worth $13,636,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the stock. SBI Securities Co. Ltd. acquired a new stake in shares of AngioDynamics in the 4th quarter valued at about $28,000. R Squared Ltd acquired a new stake in AngioDynamics in the fourth quarter valued at approximately $49,000. US Bancorp DE increased its holdings in shares of AngioDynamics by 1,938.0% during the fourth quarter. US Bancorp DE now owns 6,705 shares of the medical instruments supplier’s stock valued at $61,000 after acquiring an additional 6,376 shares in the last quarter. Quinn Opportunity Partners LLC acquired a new position in shares of AngioDynamics during the fourth quarter worth approximately $92,000. Finally, SG Americas Securities LLC lifted its holdings in shares of AngioDynamics by 21.3% in the 4th quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier’s stock worth $147,000 after purchasing an additional 2,832 shares in the last quarter. 89.43% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “buy” rating and set a $16.00 price objective (up previously from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Stock Up 5.7 %

Shares of AngioDynamics stock opened at $9.27 on Friday. The company has a market cap of $376.31 million, a PE ratio of -1.65 and a beta of 0.58. AngioDynamics, Inc. has a 52 week low of $5.47 and a 52 week high of $13.50. The business has a 50 day moving average price of $9.43 and a 200-day moving average price of $9.29.

AngioDynamics (NASDAQ:ANGO) last posted its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.16. The firm had revenue of $72.00 million for the quarter, compared to the consensus estimate of $70.30 million. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. AngioDynamics’s quarterly revenue was down 4.3% compared to the same quarter last year. As a group, research analysts anticipate that AngioDynamics, Inc. will post -0.37 EPS for the current year.

AngioDynamics Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.